Draganfly - CEO, Cameron Chell.
CEO, Cameron Chell.
Source: Global Banking and Finance.
  • Draganfly (DFLY) and Coldchain Delivery Systems have finalized a definitive agreement for medical delivery solutions worth C$750,000
  • The companies will develop, deploy and operate solutions for the delivery of medical supplies, medicine and vaccines
  • The agreement provides for phase one of a planned five-phase roll-out of a medical drone delivery service
  • Under phase two, Coldchain will commit to purchasing no less than US$625,000 in equipment and services from Draganfly
  • Coldchain Delivery Systems specializes in time and temperature-sensitive medical material management
  • Draganfly creates quality drone solutions, software and AI systems
  • Draganfly (DFLY) is down by 1.29 per cent and is currently trading at $1.53 per share

Draganfly (DFLY) and Coldchain Delivery Systems have finalized a definitive agreement for medical delivery solutions worth C$750,000.

The companies will develop, deploy and operate solutions for the delivery of medical supplies, medicine and vaccines.

The agreement provides for phase one of a planned five-phase roll-out of a medical drone delivery service, which will include working with regulatory bodies to obtain licenses for initial non-commercial beta test delivery routes.

Phase one has a value of C$125,000 and will be executed over a maximum of ten months.

Under phase two, Coldchain will commit to purchasing no less than US$625,000 in equipment and services from Draganfly.

Cameron Chell, CEO of Draganfly, commented,

“We are excited to develop a payload system that will leverage our extensive patent portfolio as well as secured auto-pilot and flight management systems. Coldchain Delivery Systems is a leader in healthcare supply chain management and we are looking forward to helping deliver via UAV medical supplies to remote areas.”

Coldchain Delivery Systems specializes in time and temperature-sensitive medical material management. Clients include the Defense Logistics Agency, the Centers for Disease Control and ‎Prevention, Johnson & Johnson and the Chicago Department of ‎Public Health.

Draganfly creates quality drone solutions, software and AI systems.

Draganfly (DFLY) is down by 1.29 per cent and is currently trading at $1.53 per share as of 11:31 am ET.

More From The Market Online

Independent tests of BlackBerry cyber defense scores solid results

A new study finds that BlackBerry’s (TSX:BB) endpoint protection platform blocked the most cyberattacks while using fewer system resources.

Buzz on the Bullboards: Looking for volatility-proof stocks?

Investors saw developments in Canadian and U.S. stock markets, with attention on decisions made by central banks and moves in key sectors.

TELUS becomes one of the first Canadian organizations to offer GenAI

TELUS (TSX:T) becomes one of the first Canadian organizations to offer GenAI solutions to its customer base.
Scientific labratory

How a small-cap tech stock is broadening MRI technology 

Nanalysis Scientific (TSXV:NSCI) develops and makes compact MRI and nuclear magnetic resonance devices for clinical, lab and industrial use.